Tirzepatide Peptide is a synthetic peptide therapeutic that belongs to a novel class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. This dual-agonist approach distinguishes tirzepatide from earlier single-receptor-targeting peptides and represents a significant advancement in metabolic medicine.
The medication is engineered as a single peptide molecule that maintains stability appropriate for pharmaceutical use while providing sustained therapeutic effects. Its molecular structure has been specifically designed to activate both GIP and GLP-1 receptors, offering what researchers describe as a more comprehensive intervention in metabolic pathways compared to single-agonist agents.


Price:
Price 5860.0 INR / Box
Minimum Order Quantity : 5 Boxes
Pacakaging (Quantity Per Box) : 1
Ingredients : Retatrutide 40mg In pharmaceutical research, the designation Retatrutide 20mg typically refers to the dosage strength being evaluated in clinical studies. The 20mg dosage represents one of several dose levels examined during the research and development process to determine the compound s safety profile, tolerability, and potential therapeutic effects. Dose Selection in Research Determining appropriate dosing levels for investigational compounds involves extensive preclinical and earlyphase clinical research. For retatrutide, researchers evaluated multiple dosage levels to understand: Safety and tolerability How different doses are tolerated by research participants Therapeutic effects What doses produce desired therapeutic outcomes Maximum tolerated dose The highest dose that can be administered without unacceptable side effects The 20mg dosage level reflects findings from these early investigations, representing a dose that balances potential therapeutic effects with acceptable tolerability.
Quantity : 5000 Boxes
Physical Form : Other
Price 5780.0 INR / Box
Minimum Order Quantity : 5 Boxes
Pacakaging (Quantity Per Box) : 1
Ingredients : In pharmaceutical research, the designation Retatrutide 20mg typically refers to the dosage strength being evaluated in clinical studies. The 20mg dosage represents one of several dose levels examined during the research and development process to determine the compound s safety profile, tolerability, and potential therapeutic effects.
Quantity : 5000 Boxes
Physical Form : Other
Price 5870.0 INR / Box
Minimum Order Quantity : 5 Boxes
Pacakaging (Quantity Per Box) : 1 Pen
Ingredients : Alluvi Retatrutide 40mg Injection Pen
Quantity : 5 Boxes
Physical Form : Other
Price 5650.0 INR / Box
Minimum Order Quantity : 5 Boxes
Pacakaging (Quantity Per Box) : 1
Ingredients : VLS RETATRUTIDE Retatrutide operates as a multiagonist, meaning it activates multiple hormone receptors at once. Specifically, this peptide targets three crucial receptors involved in metabolic function: the glucagonlike peptide1 (GLP1) receptor, the glucosedependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This tripleagonist approach distinguishes Retatrutide from existing therapies like semaglutide, which only targets the GLP1 receptor, and tirzepatide, which targets both GLP1 and GIP receptors
Quantity : 5000 Boxes
Physical Form : Other